GENERAL MANAGER, DRG TECHSYSTEMS ZAO
Dmitry Kekalo serves as General Manager of DRG TechSystems (Moscow), operating in Russia and other countries in the Commonwealth of Independent States (CIS). The company is a wholly-owned subsidiary of DRG International, Inc.
In 1992, Mr. Kekalo followed family tradition and joined DRG International, Inc. as the Sales Manager of the complete line of DRG medical equipment distributed in Russia. His mother was the first DRG Representative and Office Manager in Russia in the mid-1980’s.
Mr. Kekalo is responsible for the development of marketing and sales strategy as well as general control of all operations for the DRG group of companies in Russia. He also supervises and coordinates sales projects in Russia and CIS countries. Mr. Kekalo has been instrumental in strengthening DRG as a provider of cutting-edge technologies in medicine. Within last 20 years, DRG has been pioneering a number of well-known medical brands in Russia such as St. Jude, Datascope, Abbott Vascular, General Electric and Johnson & Johnson, to name a few.
Besides its core business of laboratory diagnostics, DRG Russia specializes in general cardiology, invasive cardiology and intensive care. Additionally, DRG Russia provides a complete range of services including delivery, customs clearance, installation, on-site training and technical support, as well as after-warranty service.
Prior to his career at DRG, Mr. Kekalo served as Marketing Manager for VLAMOS AO, a distributor of over-the-counter pharmaceutical products in Russia.
In 2008, he was invited by the American Association of Clinical Chemistry to present a report on business perspectives in Russia at the organization’s annual meeting in Chicago.
Mr. Kekalo graduated from Moscow State University with a Master of Science degree in Afro-Asian studies with a specialization in Japanese history and culture. He also received a degree in Marketing at Open University in the United Kingdom. Mr. Kekalo is fluent in Russian and English.
News and Updates
On June 4th-6th, the DRG:HYBRiD-XL Summer workshop took place in Germany with distributors from Nepal, Lebanon, and Australia. It was a very enthusiastic group! Key topics discussed included real situations in the field and Hepcidin as a new biomarker. Attendees...
DRG is proud to announce the launch of a NEW assay kit as part of DRG's Iron Panel: sTfR ELISA RUO (EIA-5925R).Specifications of the new assay kit sTfR ELISA RUO, EIA-5925R:Principle of the Assay: ELISA based on the sandwich principleAssay Range: 0.145 – 160...
DRG is proud to announce the launch of a NEW and UNIQUE assay kit of DRG's Iron Panel: Salivary Hepcidin RUO (SLV-6082R).The hormone hepcidin plays an important role in regulating iron metabolism. It is a major regulator of dietary iron absorption and iron...